Starting in the 1940s, doctors prescribed a synthetic form of estrogen thought to prevent miscarriages and other complications to millions of pregnant women in the United States.
But in 1971, diethylstilbestrol, or DES, was banned by the U.S. Food and Drug Administration after studies linked it to health problems in the children of women who used it, including infertility and a rare form of vaginal and cervical cancer. In the decades since then, children of DES users have sued pharmaceutical companies that produced the drug in courts across the country, accusing them of failing to test DES and misrepresenting it as safe.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]